PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-08-08

Date Title Company
08-Aug-2022 Invacare Reports Results for Second Quarter 2022 Businesswire
08-Aug-2022 Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress Businesswire
08-Aug-2022 Tricida Announces Second Quarter 2022 Financial Results Businesswire
08-Aug-2022 Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer Businesswire
08-Aug-2022 Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates Businesswire
08-Aug-2022 Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update Businesswire
08-Aug-2022 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET Businesswire
08-Aug-2022 CVD Equipment to Announce 2022 Second Quarter Results Businesswire
08-Aug-2022 Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update Businesswire
08-Aug-2022 Ocular Therapeutix™ Reports Second Quarter 2022 Financial Results and Business Update Businesswire
08-Aug-2022 Ligand Reports Second Quarter 2022 Financial Results Businesswire
08-Aug-2022 Rocket Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Progress Businesswire
08-Aug-2022 Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer Businesswire
08-Aug-2022 IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure IGEA Pharma N.V.
08-Aug-2022 Quality, Reliability and Longevity Make Variscite’s System on Module the Leading Choice for Medical Devices Businesswire
08-Aug-2022 Applied DNA Announces Closing of Upsized $12 Million Public Offering Businesswire
08-Aug-2022 ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide Businesswire
08-Aug-2022 Global Optical Disorders Drugs Market Report 2022: Increasing Prevalence of Age-Related Macular Degeneration Expected to Drive Growth - ResearchAndMarkets.com Businesswire
08-Aug-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fulgent Genetics, Inc. (FLGT) on Behalf of Investors Businesswire
08-Aug-2022 MedinCell: Participation Terms in the Combined General Meeting Businesswire